Post-COVID syndrome, inflammation, and diabetes
Ali A. Rizvi(Emory University), Manfredi Rizzo(Department of Health), Andrej Janež(University of Ljubljana), Yajnavalka Banerjee(Mohammed Bin Rashid University of Medicine and Health Sciences), Paulo A. Lotufo(University of Washington), Su‐Yen Goh(Singapore General Hospital), Khalid Al‐Rasadi(Sultan Qaboos University Hospital), Raul D. Santos(Hospital Israelita Albert Einstein), Mustafa Cesur(Güven Hospital), Antonio Ceriello(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Maciej Banach(Medical University of Lodz), Vijay Viswanathan(India Diabetes Research Foundation), Kamila Al-Alawi(Ministry of Health), Peter P. Tóth(University of Illinois Urbana-Champaign), Νικόλαος Παπάνας(Democritus University of Thrace), Sanjay Kalra(Bharti Hospital), Francesco Cosentino(University of Zurich), Anca Pantea Stoian(University of Bucharest), Amita Kathuria(University of Central Florida), Péter Kempler(University College London), Massimo Galia(University of Palermo), Wael Al Mahmeed, Nader Lessan(Imperial College London Diabetes Centre)
Cited by 69
Related Papers
Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015
|JAMA|2017|2.4k
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I
|European Heart Journal|2013|1.4k
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
|European Heart Journal|2023|1.4k
Is Oxidative Stress the Pathogenic Mechanism Underlying Insulin Resistance, Diabetes, and Cardiovascular Disease? The Common Soil Hypothesis Revisited
|Arteriosclerosis Thrombosis and Vascular Biology|2004|1.4k
Type 2 Diabetes Mellitus and Heart Failure: A Position Statement from the Heart Failure Association of the European Society of Cardiology
|European Journal of Heart Failure|2018|714